These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 10383009

  • 21. Dialysis-related amyloidosis.
    Bardin T, Zingraff J, Kuntz D, Drüeke T.
    Nephrol Dial Transplant; 1986; 1(3):151-4. PubMed ID: 3110668
    [No Abstract] [Full Text] [Related]

  • 22. Haemodialysis versus CAPD: equal predisposition to amyloidosis?
    Ballardie FW, Kerr DN, Tennent G, Pepys MB.
    Lancet; 1986 Apr 05; 1(8484):795-6. PubMed ID: 2870283
    [No Abstract] [Full Text] [Related]

  • 23. Dialysis-related amyloidosis of the heart in long-term hemodialysis patients.
    Takayama F, Miyazaki S, Morita T, Hirasawa Y, Niwa T.
    Kidney Int Suppl; 2001 Feb 05; 78():S172-6. PubMed ID: 11169005
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
    Rashid G, Korzets Z, Bernheim J.
    Isr Med Assoc J; 2006 Jan 05; 8(1):36-9. PubMed ID: 16450750
    [Abstract] [Full Text] [Related]

  • 28. Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis.
    Garbar C, Jadoul M, Noël H, van Ypersele de Strihou C.
    Kidney Int; 1999 May 05; 55(5):1983-90. PubMed ID: 10231463
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Behavior of beta 2-microglobulin (B2-m) serum levels in uremic patients.
    Mioli VA, Balestra E, Bibiano L, Dellabella S, Fanciulli E, Gaffi G, Perilli A, Petroselli F, Ricciatti AM, Carletti P.
    Int J Artif Organs; 1994 Nov 05; 17(11):576-80. PubMed ID: 7744516
    [Abstract] [Full Text] [Related]

  • 34. Dialysis-related amyloidosis during peritoneal dialysis.
    Brown E, Soldano L, Hendler E.
    ASAIO Trans; 1990 Nov 05; 36(1):17-20. PubMed ID: 2306386
    [Abstract] [Full Text] [Related]

  • 35. Renal transplantation relieves the symptoms but does not reverse beta 2-microglobulin amyloidosis.
    Mourad G, Argilés A.
    J Am Soc Nephrol; 1996 May 05; 7(5):798-804. PubMed ID: 8738817
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Kinetic and clinical studies of beta 2-microglobulin in continuous ambulatory peritoneal dialysis: influence of renal and enhanced peritoneal clearances using glucose polymer.
    Mistry CD, O'Donoghue DJ, Nelson S, Gokal R, Ballardie FW.
    Nephrol Dial Transplant; 1990 May 05; 5(7):513-9. PubMed ID: 2130298
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Combined Waldenström's macroglobulinaemia associated AL and beta-2-microglobulin amyloidosis.
    Jones CH, Kanagasundaram NS, Coral AP, Coyne JD, Will EJ.
    Nephrol Dial Transplant; 1997 Dec 05; 12(12):2708-12. PubMed ID: 9430877
    [No Abstract] [Full Text] [Related]

  • 40. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
    Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, D'Haenens P.
    Nephrol Dial Transplant; 2000 Dec 05; 15 Suppl 1():49-54. PubMed ID: 10737167
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.